4//SEC Filing
Baynes Roy D. 4
Accession 0001549595-25-000077
CIK 0001549595other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:32 PM ET
Size
5.5 KB
Accession
0001549595-25-000077
Insider Transaction Report
Form 4
Baynes Roy D.
Director
Transactions
- Award
Director Stock Option (right to buy)
2025-05-19+25,000→ 25,000 totalExercise: $9.51Exp: 2035-05-18→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 19, 2026, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001680739
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:32 PM ET
- Size
- 5.5 KB